Teva Pharm. United States, Inc. v. Superior Court of Cal.
134 S. Ct. 2895, 189 L. Ed. 2d 831, 82 U.S.L.W. 3746, 2014 WL 2921717, 2014 U.S. LEXIS 4528
This text of 134 S. Ct. 2895 (Teva Pharm. United States, Inc. v. Superior Court of Cal.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Teva Pharm. United States, Inc. v. Superior Court of Cal., 134 S. Ct. 2895, 189 L. Ed. 2d 831, 82 U.S.L.W. 3746, 2014 WL 2921717, 2014 U.S. LEXIS 4528 (U.S. 2014).
Opinion
The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Bluebook (online)
134 S. Ct. 2895, 189 L. Ed. 2d 831, 82 U.S.L.W. 3746, 2014 WL 2921717, 2014 U.S. LEXIS 4528, Counsel Stack Legal Research, https://law.counselstack.com/opinion/teva-pharm-united-states-inc-v-superior-court-of-cal-scotus-2014.